Patents by Inventor Raphael Bar

Raphael Bar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • High enantiomeric purity dexanabinol for pharmaceutical compositions
    Publication number: 20070060636
    Abstract: The present invention relates to a synthetic cannabinoid, dexanabinol, of enantiomeric purity in excess of 99.90%, or to a pharmaceutically acceptable salt, ester or solvate of said compound. The present invention also relates to pharmaceutical grade compositions comprising said compound of high enantiomeric purity, and uses thereof for prevention and treatment of neurological disorders, chronic degenerative diseases, CNS poisoning, cognitive impairment, inflammatory diseases or disorders, autoimmune diseases or disorders, pain, emesis, glaucoma and wasting syndromes.
    Type: Application
    Filed: August 14, 2006
    Publication date: March 15, 2007
    Inventors: Haim Aviv, Raphael Bar, Michael Schickler, Shimon Amselem
  • High enantiomeric purity dexanabinol for pharmaceutical compositions
    Publication number: 20040110827
    Abstract: The present invention relates to a synthetic cannabinoid, dexanabinol, of enantiomeric purity in excess of 99.90%, or to a pharmaceutically acceptable salt, ester or solvate of said compound. The present invention also relates to pharmaceutical grade compositions comprising said compound of high enantiomeric purity, and uses thereof for prevention and treatment of neurological disorders, chronic degenerative diseases, CNS poisoning, cognitive impairment, inflammatory diseases or disorders, autoimmune diseases or disorders, pain, emesis, glaucoma and wasting syndromes.
    Type: Application
    Filed: August 19, 2003
    Publication date: June 10, 2004
    Inventors: Haim Aviv, Raphael Bar, Michael Schickler, Shimon Amselem